CY7-SE (Synonyms: Cy7 NHS Ester, N-hydroxysuccinimidyl Ester Cy7) |
|
Catalog No.GC30261
|
CY7-SE (Cyanine7 Succinimidyl Ester) is a fluorescent dye derived from CY7. CY7-SE can directly react covalently with the amino groups (-NH₂) of biomolecules such as proteins and antibodies, without the need for additional coupling agents (Ex=747nm, Em=774nm).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 477908-53-5
Sample solution is provided at 25 µL, 10mM.
CY7-SE (Cyanine7 Succinimidyl Ester) is a fluorescent dye derived from CY7. CY7-SE can directly react covalently with the amino groups (-NH₂) of biomolecules such as proteins and antibodies, without the need for additional coupling agents (Ex=747nm, Em=774nm). CY7 is a fundamental lipophilic cyanine dye. Due to CY7 absorption in the near-infrared region, CY7 has a very low background, CY7 is the most intense and stable long-wavelength dye. CY7 is particularly suitable for in vivo imaging in small animals as an alternative to radioactive elements. However, the molecular structure of CY7 contains a positively charged mesomeric ion structure, which requires modification through carboxyl groups or other chemical modifications to enable covalent binding with biomolecules[1]. CY7-SE, on the other hand, is derived from CY7 by introducing an active ester group (-NHS), which allows CY7-SE to directly label biomacromolecules containing amino groups, including antibodies, peptides, and liposomes[2]. For example, the ovarian cancer-related antibody OC183B2 labeled with CY7-SE can clearly visualize ovarian cancer cells in real-time near-infrared fluorescence imaging[3]. Additionally, D-mannosamine labeled with CY7-SE (Cy7-DM) can bind to the mannose receptors on the surface of tumor-associated macrophages (TAMs), enabling the observation of TAM aggregation in tumor tissues through near-infrared fluorescence imaging[4].
Reference:
[1] LI Y, ZHOU Y, YUE X, et al. Cyanine Conjugate-Based Biomedical Imaging Probes [J]. Adv Healthc Mater, 2020, 9(22): e2001327.
[2] ZHANG H, YAN C, LI H, et al. Rational Design of Near-Infrared Cyanine-Based Fluorescent Probes for Rapid In Vivo Sensing Cysteine [J]. ACS Appl Bio Mater, 2021, 4(3): 2001-2008.
[3] ZHANG C, LING X, GUO Y, et al. Evaluation of COC183B2 antibody targeting ovarian cancer by near-infrared fluorescence imaging [J]. Chin J Cancer Res, 2019, 31(4): 673-685.
[4] JIANG C, CAI H, PENG X, et al. Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors [J]. Mol Imaging, 2017, 16(1536012116689499.
Labeling Protein[1]:
Antibodies containing other proteins (e.g., serum albumin or gelatin) or buffers with amino groups can affect labeling and need to be purified before labeling.
1.Dialyze anti-GST antibody (0.5mL at 3mg/mL) in 1L of 0.15M NaCl solution at room temperature for 4 hours.
2.Dialyze overnight in a fresh 1 L of 0.15M NaCl solution at 4°C.
3.On the next day, dialyze for 4 hours in 1L of 0.1M NaHCO₃ (pH 8.3).
4.Filter the antibody solution using a 0.22-μm syringe filter.
5.Dilute a small amount of the antibody with 0.1M NaHCO₃ and measure its UV absorbance at 280nm to calculate the total amount of the antibody.
6.Prepare a Cy7-SE solution in DMSO at a concentration of 10mg/mL. Calculate the required volume to achieve the desired ratio of CyDye NHS to antibody (e.g., 20:1), and then slowly add it to the antibody solution. Stir gently in the dark at room temperature for 45min.
7.Dialyze for 4 hours at room temperature in the dark using 1L of 0.15M NaCl solution to remove unbound Cy7-SE.
8.Dialyze overnight in the dark at 4°C using a fresh 1L of 0.15M NaCl solution.
9.Dialyze for 4 hours at room temperature in the dark using 1L of 0.01M PBS/0.01% sodium azide solution, and then dialyze again overnight at 4°C in the dark.
10.Filter the antibody solution using a 0.22μm syringe filter.
11.Dilute the labeled antibody solution with 0.01M PBS/0.01% sodium azide to a convenient concentration, and measure the UV-Vis absorbance at 280nm (protein) and 552nm (Cy).
12.Dissolve the CY7-SE-labeled protein in PBS solution (pH=7.2-7.4).
13.Intravenous injection of 200μL (0.5mg/mL) into the tail vein of mice.
14.Imaging pictures of in vivo fluorescence were recorded to analyze the distribution of the fluorescent drug.
15.The excitation wavelength was 700–770nm bandpass, and the emission wavelength was 790nm longpass.
To calculate the F/P (fluorophore-to-protein) ratio, follow these steps:
The molar extinction coefficient of Cy7 at 750nm is 240600M⁻¹cm⁻¹; the molar extinction coefficient of this protein at 280nm is 170,000M⁻¹cm⁻¹. Different proteins have different molar extinction coefficients. The absorption of Cy7 dye itself at 280nm is 4% of its absorption at 750nm. The F/P value is calculated using the following formulas:
[Cy7] = A750/240600
[antibody] = {A280 - (0.04×A750)}/170000
F/P final= [Cy7]/[antibody]= {0.71×A750}/ {A280 - (0.04×A750)}
Reference:
[1] ZHANG C, CHENG H, DOU S, et al. Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer [J]. J Ovarian Res, 2024, 17(1): 225.
| Cas No. | 477908-53-5 | SDF | |
| Synonyms | Cy7 NHS Ester, N-hydroxysuccinimidyl Ester Cy7 | ||
| Canonical SMILES | CC(/C(N1CCCCCC(ON2C(CCC2=O)=O)=O)=C\C=C\C=C\C=C\C3=[N+](CC)C(C=CC(S(=O)([O-])=O)=C4)=C4C3(C)C)(C)C5=C1C=CC(S(=O)(O)=O)=C5 | ||
| Formula | C39H45N3O10S2 | M.Wt | 779.92 |
| Solubility | DMSO : ≥ 41 mg/mL (52.57 mM) | Storage | Store at -20°C, protect from light |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.2822 mL | 6.4109 mL | 12.8218 mL |
| 5 mM | 256.4 μL | 1.2822 mL | 2.5644 mL |
| 10 mM | 128.2 μL | 641.1 μL | 1.2822 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 37 reference(s) in Google Scholar.)















